COVID-19 PHASE 2 CLINICAL EVALUATION OF USB002 (ANGIOTENSIN 1-7) FOR THE TREATMENT OF PULMONARY DISTRESS DUE TO COVID-19

U.S. Biotest, Inc

Investigators